A class of medications best known for treating diabetes and obesity may also reduce the risk of addiction—and help people who already have one, a new study shows. Semaglutide (also known as Ozempic), ...

The findings suggest the drugs may influence parts of the brain involved in cravings and reward. A study published in the British Medical Journal analysed medical records from 606,434 US veterans ...

New Delhi: Medications that have gained global attention for helping people lose weight and manage diabetes may be influencing something else as well — substance addiction. A large study published in ...

GLP-1 receptor agonists may reduce the risk of developing and dying from substance use disorders, a study found. The study, led by researchers at St. Louis-based WashU Medicine and published March 4 ...

Please provide your email address to receive an email when new articles are posted on . GLP-1s were tied to lower risks for incident substance use disorders in people with type 2 diabetes. For those ...

A massive study of more than 600,000 U.S. veterans suggests that popular GLP-1 drugs such as semaglutide may do far more than help with diabetes and weight loss—they could also fight addiction itself.

From online forums to the clinic, people have reported that diabetes and weight-loss drugs such as Ozempic and Wegovy can dramatically quell their compulsive behaviors—including cravings for alcohol ...

A patient of mine, a veteran who had tried to quit smoking for over a decade, told me that after he started a GLP-1 drug for his diabetes, he lost interest in cigarettes. He didn’t use a patch. He ...